Efficacy and Safety of Fruquintinib Plus PD-1 Inhibitors Versus Regorafenib Plus PD-1 Inhibitors in Refractory Microsatellite Stable Metastatic Colorectal Cancer

BACKGROUND: Microsatellite stability (MSS) or mismatch repair proficient (pMMR) metastatic colorectal cancer (mCRC) is resistant to immune checkpoint inhibitors. Studies have shown that antiangiogenic drugs combined with programmed death receptor-1 (PD-1) inhibitors can improve immunosuppression. Th...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Liying, Huang, Shenglan, Li, Dan, Mao, Ye, Wang, Yurou, Wu, Jianbing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8526894/
https://www.ncbi.nlm.nih.gov/pubmed/34692541
http://dx.doi.org/10.3389/fonc.2021.754881

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8526894/
https://www.ncbi.nlm.nih.gov/pubmed/34692541
http://dx.doi.org/10.3389/fonc.2021.754881

Ejemplares similares